NCTM advises DOC Generici management on acquisition by Charterhouse Capital Partners
NCTM Studio Legale Associato has advised the management of pharmaceutical group DOC Generici — owned by Apotex, Chiesi Farmaceutici and Zambon — on the group’s buyout by private equity fund Charterhouse Capital Partners.
The NCTM team was led by Pietro Zanoni and made up of Francesca Bonino, Roberta Russo and Barbara Aloisi.
During the acquisition, Chiomenti Studio Legale assisted the buyer Charterhouse with Franco Agopyan (M&A), Luca Bonetti (finance), Paolo Giacometti (tax) and Stefania Bariatti (filing antitrust), while the vendors — Zambon, Chiesi Farmaceutici and Apotex — were assisted by Freshfields with Nicola Asti, Leonardo Graffi and Niccolò Gandini.
Rothschild acted as financial adviser to the vendors.
News from NCTM
News from The Lawyer
Briefings from NCTM
Geographical indications (GIs) for foodstuffs are protected under European law, while GIs for non-foodstuffs are not protected under EU law. Should we keep this difference?
In the last couple of days, the Financial Times and The New York Times have published important articles on Russia and China. The articles don’t pull their punches.
Analysis from The Lawyer
Being sent to London on secondment is a prized opportunity for associates in European firms